Package Leaflet: Information for the User
Diliban 75 mg/650 mg Tablets
Tramadol Hydrochloride/Paracetamol
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
Diliban is a combination of two painkillers, tramadol and paracetamol, which work together to relieve pain. Diliban is indicated for the symptomatic treatment of moderate to severe pain, when your doctor considers that a combination of tramadol and paracetamol is necessary.
Diliban should only be used by adults and children over 12 years of age.
Do not take Diliban:
Warnings and precautions:
Consult your doctor before starting to take Diliban:
During treatment with Diliban, inform your doctor immediately:
If you have or have had any of these problems while taking Diliban, inform your doctor. He will decide if you should continue taking this medicine.
Sleep-related breathing disorders
Diliban may cause sleep-related breathing disorders, such as sleep apnea (pauses in breathing during sleep) and sleep-related hypoxemia (low oxygen level in the blood). Among the symptoms may include pauses in breathing during sleep, nighttime awakenings due to shortness of breath, difficulty maintaining sleep, or excessive daytime sleepiness. If you or someone else observes these symptoms, contact your doctor. Your doctor may consider a dose reduction.
There is a weak risk that you may experience a serotonin syndrome that can occur after taking tramadol in combination with certain antidepressants or tramadol alone. Consult your doctor immediately if you experience any of the symptoms associated with this serious syndrome (see section 4 "Possible side effects").
Tramadol is transformed in the liver by an enzyme. Some people have a variation of this enzyme, and this can affect each person differently. In some people, sufficient pain relief may not be achieved, while others are more likely to experience serious side effects. If you notice any of the following side effects, you should stop taking this medicine and consult a doctor immediately: slow or shallow breathing, confusion, drowsiness, constricted pupils, general malaise, or vomiting, constipation, loss of appetite.
Tolerance, dependence, and addiction
This medicine contains tramadol, which is an opioid medicine. Repeated use of opioids can make the medicine less effective (you get used to it, which is known as tolerance). Repeated use of Diliban can also lead to dependence, abuse, and addiction, which can result in a potentially fatal overdose. The risk of these side effects may increase with a higher dose and longer use.
Dependence or addiction can make you feel like you no longer control the amount of medicine you need to take or how often you need to take it.
The risk of becoming dependent or addicted varies from person to person. You may have a higher risk of becoming dependent or addicted to Diliban if:
If you notice any of the following signs while taking Diliban, it could be a sign that you have become dependent or addicted:
If you observe any of these signs, talk to your doctor so that he can indicate the best course of treatment for you, including when it is appropriate to stop taking it and how to do it safely (see section 3, "If you stop taking Diliban").
Children and adolescents
Use in children with respiratory problems
Tramadol is not recommended for use in children with respiratory problems, as the symptoms of tramadol toxicity can worsen in these children.
Other medicines and Diliban:
Tell your doctor or pharmacist if you are using or have recently used any other medicines, including those obtained without a prescription.
Inform your doctor or pharmacist if you are taking:
Important:This medicine contains paracetamol and tramadol. Inform your doctor if you are taking any other medicine that contains paracetamol or tramadol, so that you do not exceed the maximum daily dose.
Do not take Diliban with monoamine oxidase inhibitors (MAOIs) (see "Do not take Diliban").
Diliban is not recommended if you are being treated with:
The risk of side effects increases if you also use:
-Triptans (for the treatment of migraines) or selective serotonin reuptake inhibitors "SSRIs" (for the treatment of depression). If you experience confusion, agitation, fever, sweating, uncoordinated movements of the limbs or eyes, uncontrolled muscle contractions, or diarrhea, you should call your doctor.
-Medicines for the treatment of depression. Diliban can interact with these medicines, and you may experience a serotonin syndrome (see section 4 "Possible side effects").
However, if your doctor prescribes Diliban with sedative medicines, your doctor should limit the dose and duration of concomitant treatment.
Please inform your doctor about all sedative medicines you are taking and closely follow your doctor's dose recommendation. It may be useful to inform friends or family members to be alert to the signs and symptoms indicated above. Contact your doctor when you experience these symptoms.
The effectiveness of Diliban may be altered if you also use:
Your doctor will know which medicines are safe to use with Diliban.
Taking Diliban with food, drinks, and alcohol:
Do not drink alcoholic beverages if you are taking this medicine.
Pregnancy, breastfeeding, and fertility:
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Because Diliban contains tramadol, it is not recommended to use this medicine during pregnancy. If you become pregnant during treatment with Diliban, consult your doctor before taking the next tablet.
Tramadol is excreted in breast milk. For this reason, you should not take Diliban more than once during breastfeeding, or if you take Diliban more than once, you should interrupt breastfeeding.
Driving and using machines:
Ask your doctor if you can drive or use machines during treatment with this medicine. It is important that before driving or using machines, you observe how this medicine affects you. Do not drive or use machines if you feel drowsy, dizzy, have blurred vision, or double vision, or have difficulty concentrating. Be especially careful at the start of treatment, after a dose increase, after a change in formulation, and/or when administering it in combination with other medicines.
Follow the instructions for administration of this medicine exactly as indicated by your doctor. If you are in doubt, consult your doctor or pharmacist again.
Before starting treatment and regularly during treatment, your doctor will explain what you can expect from the use of Diliban, when and for how long you should take it, when you should contact your doctor, and when you should stop it (see also section 2).
You should take Diliban for the shortest possible time.
The dose should be adjusted to the intensity of your pain and your individual sensitivity to pain. Normally, you should take the lowest possible dose that provides pain relief.
Unless your doctor prescribes otherwise, the recommended starting dose for adults and adolescents over 12 years of age is 1 tablet.
If necessary, you can increase the dose, as recommended by your doctor. The shortest interval between doses should be at least 6 hours.
Do not take more than 4 Diliban tablets per day.
Do not take Diliban more frequently than indicated by your doctor.
Your doctor may increase the interval between doses:
Elderly patients
In elderly patients (over 75 years old), the elimination of tramadol may be slow. If this is your case, your doctor may recommend prolonging the dosing intervals.
Patient with liver or kidney failure/patients on dialysis
If you have severe liver or kidney disease, treatment with Diliban is not recommended. If you have moderate liver or kidney problems, your doctor may prolong the dosing intervals.
Use in children and adolescents:
Diliban is not recommended for use in children under 12 years of age.
Method of administration:
The tablets can be taken whole or broken in half with the help of a glass of liquid, preferably water. The score line on the tablet is to break the tablet if you find it difficult to swallow whole or if you need to take half a dose.
If you think the effect of Diliban is too strong (i.e., you feel very drowsy or have difficulty breathing) or too weak (i.e., you do not have adequate pain relief), tell your doctor.
If you take more Diliban than you should:
You should consult your doctor or pharmacist, even if you feel well. There is a risk that liver damage may occur, which may only become apparent later.
In case of overdose or accidental ingestion, go immediately to a medical center or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Diliban:
If you forget to take the tablets, it is possible that the pain will return. Do not take a double dose to make up for the forgotten doses, simply continue taking the tablets as usual.
If you stop taking Diliban:
Generally, no unwanted effects occur after stopping treatment with Diliban. However, it may be the case that patients who have been taking Diliban for a long time and have stopped treatment abruptly feel unwell (see section 4 "Possible side effects"). You should not stop taking this medicine suddenly unless your doctor tells you to. If you want to stop taking your medicine, talk to your doctor first, especially if you have been taking it for a long time. Your doctor will inform you when and how to stop it, which can be done by gradually reducing the dose to reduce the likelihood of unnecessary side effects (withdrawal symptoms).
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Diliban can have adverse effects, although not all people suffer from them.
Very frequent: can affect more than 1 in 10 patients;
Frequent: can affect between 1 and 10 out of 100 patients;
Infrequent: can affect between 1 and 10 out of 1,000 patients;
Rare: can affect between 1 and 10 out of 10,000 patients;
Frequency not known: cannot be estimated from the available data;
The following recognized adverse effects have been reported by people who have taken medicines that contained only tramadol or only paracetamol. However, if you experience any of these symptoms while taking Diliban, you should tell your doctor:
If this happens to you, stop treatment and consult your doctor immediately. You should not take this medicine again.
Using a medicine like tramadol can create dependence, making it difficult to stop taking it.
People who have been taking tramadol for some time may feel unwell if they stop treatment abruptly. They may feel agitated, anxious, nervous, or trembly. They may be hyperactive, have difficulty sleeping, and have digestive and intestinal disorders. Very few people may also have panic attacks, hallucinations, unusual perceptions such as itching, tingling sensation, and numbness, and ringing in the ears (tinnitus). If you experience any of these symptoms after stopping treatment with Diliban, please consult your doctor.
In exceptional cases, blood tests reveal abnormalities, such as low platelet count, which can result in nosebleeds or bleeding gums.
The use of Diliban together with anticoagulants (e.g., femprocumon, warfarin) may increase the risk of bleeding. You should inform your doctor immediately about any prolonged or unexpected bleeding.
In very rare cases, serious skin reactions have been reported.
Reporting of Adverse Effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is an adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep out of the reach and sight of children.
Store this medicine in a safe and protected place, where other people cannot access it. It can cause serious harm and be fatal for people who have not been prescribed it.
This medicine does not require special storage conditions.
Do not use Diliban after the expiration date that appears on the packaging (after CAD).
The expiration date is the last day of the month indicated.
Do not use this medicine if you observe visible signs of deterioration.
Medicines should not be thrown away through the sewers or in the trash. Deposit the packaging and medicines you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Diliban:
The active ingredients are tramadol hydrochloride and paracetamol.
One tablet contains 75 mg of tramadol hydrochloride and 650 mg of paracetamol.
The other components are: Povidone, magnesium stearate, anhydrous colloidal silica, sodium carboxymethylcellulose (Type A) of potato and pregelatinized corn starch.
Appearance of the Product and Package Contents:
Diliban is presented in the form of oral tablets, in packages of 20 and 60 tablets.
Marketing Authorization Holder:
Laboratorios Gebro Pharma, S.A.
Avenida Tibidabo, 29
08022 Barcelona
Manufacturer:
GEBRO PHARMA GmbH
A-6391 Fieberbrunn (Austria)
or
Ferrer Internacional, S.A.
Joan Buscallà, 1-9
Sant Cugat del Vallès (Barcelona)
This prospectus was revised in February 2025.
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)
http://www.aemps.gob.es
The average price of DILIBAN 75 mg/650 mg TABLETS in October, 2025 is around 5.92 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.